World Health Organization starts vaccination campaign in Iraq; Daiichi Sankyo recalls 8 vaccine lots;

> In an effort to contain a major cholera outbreak in Iraq, the World Health Organization has kick-started a campaign to vaccinate 255,000 people there against the illness within a month. Report

> Daiichi Sankyo recalled two lots of a freeze-dried live attenuated measles vaccine and 6 lots of a measles and rubella combined vaccine. Report

> TapImmune relocated its corporate headquarters from Seattle to Jacksonville, FL, to prepare for Phase II breast cancer vaccine trials next year in conjunction with the Mayo Clinic in Florida. Report

> Research published in The Journal of Infectious Diseases this week suggested that statins could negatively impact the protective qualities of flu vaccines. Report

> Saint Louis University received a $5.8 million National Institutes of Health contract for an "omics" research initiative into the safety and effectiveness of vaccines and other methods to combat infectious diseases. Release

Suggested Articles

Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.